Hospital Nacional Edgardo Rebagliati Martins, Av. Edgardo Rebagliati #490 - Jesus Maria, Lima, Peru;
Center for Interdisciplinary Biomedical Education and Research, University of Central Oklahoma, Edmond, Oklahoma 73034, USA;
Department of Oncology, the First Affiliated Hospital of Chinese PLA General Hospital, Beijing 100048, China,Department of Laser Medicine, Chinese PLA General Hospital, Beijing 100853, China;
Immunophotonics Inc., 4041 Forest Park Avenue St. Louis, Missouri 63108, USA;
Immunophotonics Inc., 4041 Forest Park Avenue St. Louis, Missouri 63108, USA;
Immunophotonics Inc., 4041 Forest Park Avenue St. Louis, Missouri 63108, USA;
Center for Interdisciplinary Biomedical Education and Research, University of Central Oklahoma, Edmond, Oklahoma 73034, USA;
laser immunotherapy (LIT); metastatic cancers; Phase Ⅱ clinical trial; late-stage breast cancers; triple negative breast cancer;
机译:2110 POSTER NGcGM3 / VSSP / Montanide ISA-51(CIMAVaxG)疫苗的主动特异性免疫疗法在转移性乳腺癌患者中的治疗:一项随机II期临床试验的结果
机译:国际,第3阶段试验:Balixafortide(CXCR4拮抗剂)加二林蛋白与Eribulin单独服用Her2阴性,局部复发或转移性乳腺癌(堡垒)国际,第3阶段试验:Balixafortide(A CXCR4拮抗剂)加二林蛋白与二林林单独相反 HER2阴性,局部复发或转移性乳腺癌(堡垒)的患者
机译:一项2期试验探讨了强力霉素与骨靶向疗法联合治疗转移性乳腺癌患者的临床及相关作用
机译:激光免疫疗法对转移性癌症患者的临床效果
机译:Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
机译:I期临床试验中免疫治疗剂治疗转移性乳腺癌患者的临床结果
机译:一项2期试验探讨了强力霉素与骨靶向疗法联合治疗转移性乳腺癌患者的临床及相关作用
机译:将少数患者纳入乳腺癌临床试验:临床试验环境的作用